Results 131 to 140 of about 6,742,024 (351)

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer

open access: yesMolecular Oncology, EarlyView.
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon   +13 more
wiley   +1 more source

Soft tissue injuries in intraarticular fractures of the distal end of the radius and their effects on wrist function

open access: yesActa Orthopaedica et Traumatologica Turcica, 2021
Objectives: This study was designed to evaluate the frequency of soft tissue lesions in intra-articular fractures of the distal end of the radius and their effects on functional outcome.
Mustafa Ozkan   +4 more
doaj  

Surgical Control of Behavior [PDF]

open access: yes, 1974
Dr. Kanoti is an associate professor of Christian Ethics at John Carroll University, Cleveland, Ohio. He has published numerous articles on ethical topics, moral theology and psychology.
Kanoti, George A.
core   +1 more source

LDAcoop: Integrating non‐linear population dynamics into the analysis of clonogenic growth in vitro

open access: yesMolecular Oncology, EarlyView.
Limiting dilution assays (LDAs) quantify clonogenic growth by seeding serial dilutions of cells and scoring wells for colony formation. The fraction of negative wells is plotted against cells seeded and analyzed using the non‐linear modeling of LDAcoop.
Nikko Brix   +13 more
wiley   +1 more source

Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition

open access: yesMolecular Oncology, EarlyView.
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li   +10 more
wiley   +1 more source

Infrared laser sampling of low volumes combined with shotgun lipidomics reveals lipid markers in palatine tonsil carcinoma

open access: yesMolecular Oncology, EarlyView.
Nanosecond infrared laser (NIRL) low‐volume sampling combined with shotgun lipidomics uncovers distinct lipidome alterations in oropharyngeal squamous cell carcinoma (OPSCC) of the palatine tonsil. Several lipid species consistently differentiate tumor from healthy tissue, highlighting their potential as diagnostic markers.
Leonard Kerkhoff   +11 more
wiley   +1 more source

PECULIARITIES OF SURGICAL TREATMENT OF BENIGN FORMATION OF MAMMARY GLAND

open access: yesАктуальні проблеми сучасної медицини, 2019
The effectiveness of the use of remote surgical approaches in patients with benign formation of mammary gland was studied in this paper,. Before surgery, all patients underwent a standard set of instrumental examinations: mammography, ultrasound ...
Vitalii Makarov
doaj  

Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients.

open access: yesNew England Journal of Medicine, 2016
M. Leon   +33 more
semanticscholar   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

open access: yesMolecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala   +15 more
wiley   +1 more source

From Incision to Immunity: Integrating Surgery and Immunotherapy in Non-Small Cell Lung Cancer

open access: yesImmuno
Lung cancer is the most common cause of death due to cancer in the world, and non-small cell lung cancer (NSCLC) is the most common form of lung cancer, representing approximately 84% of all cases.
Michael J. Janes   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy